Tierney Robert JR Buys Shares of CME Group
Company insider Tierney Robert JR acquired 645 shares of CME Group on June 25, 2026.
Key Points
- Tierney Robert JR bought 645 shares of CME Group Inc. (CME) at $225 per share, totaling $145,125 on June 25, 2026.
- CME Group Inc. has a market cap of $79.85 billion, a P/E ratio of 18.87, and a 52-week range of $220.73 to $329.16.
- Rothschild & Co upgraded CME Group to 'buy' with a $323 price target on June 11, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Tierney Robert JR, an insider at CME Group Inc. (NasdaqGS: CME), purchased 645 shares of the company on June 25, 2026. The shares were acquired at an average price of $225 each, totaling a transaction value of $145,125. This transaction was not part of a pre-planned trading arrangement.
Other Institutional Activity in CME Group
Several major institutional investors have also made moves in CME Group recently. BlackRock, Inc. added 370,381 shares, bringing its total to 31,448,257 shares valued at about $9.29 billion, reflecting a 1.2% increase. Vanguard Capital Management LLC opened a new position with 23,367,282 shares worth approximately $6.90 billion. State Street Corp, on the other hand, reduced its holdings by 89,238 shares, ending with 16,055,287 shares valued at roughly $4.74 billion, marking a 0.6% decrease. JPMorgan Chase & Co increased its stake by 1,108,304 shares to 12,209,761 shares, valued at $3.63 billion, representing a 10% increase. Morgan Stanley also grew its holdings by 1,043,692 shares, ending with 9,406,843 shares worth about $2.78 billion, a 12.5% increase.
CME Group Inc. Stock Down 23.5%
Shares of CME Group Inc. traded near $221.00 on Tuesday. The company, with a market capitalization of $79.85 billion, maintains a P/E ratio of 18.87 and a beta of 0.244. The stock's 52-week range spans from $220.73 to $329.16, with a 50-day moving average of $273.98 and a 200-day moving average of $280.89. The company's financial stability is reflected in a current ratio of 1.018 and a quick ratio of 0.021, alongside a debt-to-equity ratio of 14.059.
$CME stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
CME Group reported revenue of $6.74 billion, showing a growth of 14.4%. The company's net margin stands at 63.32%, with a return on equity of 15.92%. Earnings per share are reported at $11.71. Investors are looking forward to the next earnings report scheduled for July 22, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group pays an annual dividend of $5.20, yielding 2.35% based on current prices. The dividend payout ratio is a high 95.56%, indicating a significant portion of earnings is returned to shareholders.
Insider Buying and Selling at CME Group Inc.
In addition to Tierney Robert JR's purchase, several other insiders also acquired shares on June 25, 2026, at $225 each. Phyllis Lockett, Howard Siegel, William Shepard, Rahael Seifu, Bryan Durkin, and Patrick Maloney each bought 645 shares, reflecting continued insider confidence in the company's prospects.
Analysts Set New Price Targets
On June 11, 2026, Rothschild & Co upgraded CME Group to a 'buy' rating, setting a price target of $323. Morgan Stanley maintained its 'buy' rating with a target of $353 on April 23, 2026. Barclays has consistently held a 'hold' rating, with their latest target set at $316. Overall, the consensus among 15 analysts is a 'buy', with an average target price of $302.60.
About CME Group
CME Group Inc., headquartered in Chicago, Illinois, is a leading financial services company operating global markets for the trading of futures and options. The company provides trading platforms for interest rates, equity indexes, foreign exchange, and commodities. Under the leadership of CEO Terrence A. Duffy, CME Group offers clearing house services and market data to a diverse clientele, including professional traders, financial institutions, and governments.
Bottom Line
Tierney Robert JR's recent purchase of CME Group shares highlights ongoing insider interest in the company. CME Group, with its robust market presence and strong financials, continues to attract institutional investment. Analysts remain optimistic, reflected in the recent upgrade and positive price targets. However, remember that insider transactions like these are disclosed after the fact and may not indicate the insider's current stance.
Get CME Group Inc. alerts
New 13F filings, insider trades, and analyst moves on $CME, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
